Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest Expense - DebtInterest Expense - DepositsInterest Expense - Fed FundsInterest ExpensesInterest Income - Debt SecuritiesInterest Income - Fed FundsInterest Income - NetInterest Income - TotalInterest income - LoansInvestment Banking IncomeInvestment Gain (Loss)Mortgage BankingNet Income towards Common StockholdersNon Operating Investment IncomeNon-Interest IncomeOperating ExpensesOther Non Operating IncomeOther Non-Interest IncomeOther Operating ExpensesProfit After TaxProvisionsRent ExpenseResearch & DevelopmentRestructuring CostsRevenueShares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Equity Bancshares (EQBK) Research & Development: 2016-2025

Historic Research & Development for Equity Bancshares (EQBK) over the last 10 years, with Sep 2025 value amounting to $4.9 million.

  • Equity Bancshares' Research & Development fell 5.14% to $4.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.0 million, marking a year-over-year increase of 2.71%. This contributed to the annual value of $20.0 million for FY2024, which is 14.75% up from last year.
  • Equity Bancshares' Research & Development amounted to $4.9 million in Q3 2025, which was down 3.32% from $5.1 million recorded in Q2 2025.
  • In the past 5 years, Equity Bancshares' Research & Development registered a high of $5.2 million during Q3 2024, and its lowest value of $2.7 million during Q1 2021.
  • For the 3-year period, Equity Bancshares' Research & Development averaged around $4.8 million, with its median value being $4.9 million (2025).
  • Per our database at Business Quant, Equity Bancshares' Research & Development surged by 41.53% in 2022 and then declined by 5.14% in 2025.
  • Equity Bancshares' Research & Development (Quarterly) stood at $3.9 million in 2021, then increased by 12.08% to $4.3 million in 2022, then climbed by 3.16% to $4.5 million in 2023, then grew by 11.56% to $5.0 million in 2024, then declined by 5.14% to $4.9 million in 2025.
  • Its Research & Development was $4.9 million in Q3 2025, compared to $5.1 million in Q2 2025 and $5.1 million in Q1 2025.